Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,545,942
+$194,906 QoQ
Shares Held
21,837
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#1,545
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $25,620,221 across 16 Drug Manufacturers - General names. JNJ ranks #1 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
21,837 | $5,545,942 | |
| 2 | ABBV |
AbbVie Inc.
|
19,010 | $4,783,676 | |
| 3 | LLY |
ELI LILLY & Co
|
3,909 | $4,688,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,199 | $4,651,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,282 | $1,678,047 | |
| 6 | AMGN |
Amgen Inc
|
4,076 | $1,476,001 | |
| 7 | PFE |
Pfizer Inc
|
33,216 | $799,841 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,165 | $758,567 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,545,942 | 21,837 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,351,036 | 21,891 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,632,782 | 22,386 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,998,767 | 21,566 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,958,974 | 25,918 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,759,457 | 34,729 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,928,360 | 34,078 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,676,475 | 35,027 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $5,096,014 | 34,866 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,533,960 | 34,983 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,283,235 | 33,707 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,231,019 | 33,586 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,423,428 | 32,766 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,953,860 | 38,412 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $6,648,046 | 37,634 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,394,147 | 33,020 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,869,190 | 33,064 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $5,432,631 | 30,653 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,192,145 | 30,351 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,778,623 | 29,589 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,850,439 | 29,443 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,958,932 | 30,173 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,002,330 | 25,431 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,790,931 | 25,463 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,569,048 | 25,379 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $3,259,105 | 24,854 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||